Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Henry R. Kranzler |
Documentos disponibles escritos por este autor (7)
Refinar búsquedaTopiramate versus naltrexone for alcohol use disorder: a genotype-stratified double-blind randomized controlled trial / Kirsten C. Morley en The American Journal of Psychiatry, Año 2024 - Vol. 181 - No. 5 (Mayo)
Título : Topiramate versus naltrexone for alcohol use disorder: a genotype-stratified double-blind randomized controlled trial Tipo de documento: texto impreso Autores: Kirsten C. Morley, Autor ; Henry R. Kranzler, Autor Fecha de publicación: 2025 Artículo en la página: pp. 403-411 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno por consumo de alcohol, GRIK1, Naltrexona, OPRM1, Farmacogenética, Topiramato. Resumen: There have been no well-controlled and well-powered comparative trials of topiramate with other pharmacotherapies for alcohol use disorder (AUD), such as naltrexone. Moreover, the literature is mixed on the effects of two polymorphisms—rs2832407 (in GRIK1) and rs1799971 (in OPRM1)—on response to topiramate and naltrexone, respectively. Link: ./index.php?lvl=notice_display&id=31505
in The American Journal of Psychiatry > Año 2024 - Vol. 181 - No. 5 (Mayo) . - pp. 403-411[artículo] Topiramate versus naltrexone for alcohol use disorder: a genotype-stratified double-blind randomized controlled trial [texto impreso] / Kirsten C. Morley, Autor ; Henry R. Kranzler, Autor . - 2025 . - pp. 403-411.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2024 - Vol. 181 - No. 5 (Mayo) . - pp. 403-411
Palabras clave: Trastorno por consumo de alcohol, GRIK1, Naltrexona, OPRM1, Farmacogenética, Topiramato. Resumen: There have been no well-controlled and well-powered comparative trials of topiramate with other pharmacotherapies for alcohol use disorder (AUD), such as naltrexone. Moreover, the literature is mixed on the effects of two polymorphisms—rs2832407 (in GRIK1) and rs1799971 (in OPRM1)—on response to topiramate and naltrexone, respectively. Link: ./index.php?lvl=notice_display&id=31505
Título : A double blind, randomized trial of sertraline for alcohol dependence Moderation by age of onset and 5-hydroxytryptamine transporter linked promoter region genotype Tipo de documento: texto impreso Autores: Henry R. Kranzler, Autor ; Stephen Armeli, Autor ; Howard Tennen, Autor Fecha de publicación: 2022 Artículo en la página: pp. 22-30 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: ISRS, Edad de inicio, Dependencia alcohólica, 5-HTTLPR, Farmacogenética, Respuesta al tratamiento Resumen: Late-onset/low-vulnerability alcoholics (LOAs) appear to drink less when treated with a selective serotonin reuptake inhibitor than placebo, whereas early-onset/high-vulnerability alcoholics (EOAs) show the opposite effect. We conducted a 12-week, parallel-group, placebo-controlled trial of the efficacy of sertraline in alcohol dependence (AD). Link: ./index.php?lvl=notice_display&id=29404
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 1 (Febrero) . - pp. 22-30[artículo] A double blind, randomized trial of sertraline for alcohol dependence Moderation by age of onset and 5-hydroxytryptamine transporter linked promoter region genotype [texto impreso] / Henry R. Kranzler, Autor ; Stephen Armeli, Autor ; Howard Tennen, Autor . - 2022 . - pp. 22-30.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 1 (Febrero) . - pp. 22-30
Palabras clave: ISRS, Edad de inicio, Dependencia alcohólica, 5-HTTLPR, Farmacogenética, Respuesta al tratamiento Resumen: Late-onset/low-vulnerability alcoholics (LOAs) appear to drink less when treated with a selective serotonin reuptake inhibitor than placebo, whereas early-onset/high-vulnerability alcoholics (EOAs) show the opposite effect. We conducted a 12-week, parallel-group, placebo-controlled trial of the efficacy of sertraline in alcohol dependence (AD). Link: ./index.php?lvl=notice_display&id=29404
Título : Overview of Alcohol Use Disorder Tipo de documento: texto impreso Autores: Henry R. Kranzler, Autor Fecha de publicación: 2024 Artículo en la página: pp. 565-572 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos adictivos y relacionados con sustancias, Alcohol, Psicofarmacología Resumen: Alcohol is regularly consumed throughout most of the world, including by nearly half the U.S. population age 12 or older. Heavy drinking, which is also common, contributes to multiple adverse medical, psychiatric, and social outcomes and more than 140,000 deaths annually in the United States. It is the major risk factor for alcohol use disorder (AUD), whose current U.S. prevalence is 11%. Link: ./index.php?lvl=notice_display&id=31305
in The American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 8 (Agosto) . - pp. 565-572[artículo] Overview of Alcohol Use Disorder [texto impreso] / Henry R. Kranzler, Autor . - 2024 . - pp. 565-572.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2023 - Vol. 180 - No. 8 (Agosto) . - pp. 565-572
Palabras clave: Trastornos adictivos y relacionados con sustancias, Alcohol, Psicofarmacología Resumen: Alcohol is regularly consumed throughout most of the world, including by nearly half the U.S. population age 12 or older. Heavy drinking, which is also common, contributes to multiple adverse medical, psychiatric, and social outcomes and more than 140,000 deaths annually in the United States. It is the major risk factor for alcohol use disorder (AUD), whose current U.S. prevalence is 11%. Link: ./index.php?lvl=notice_display&id=31305
Título : Pharmacologic treatments for drug and alcohol dependence Tipo de documento: texto impreso Autores: Henry R. Kranzler, Autor ; Hetal Amin, Autor ; Vania Modesto-Low, Autor Fecha de publicación: 2020 Artículo en la página: pp. 401-423 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo - farmacoterapia, Antidepresivos, Trastornos relacionados con cocaína, Metadona, Narcóticos, Trastornos relacionados con opioides, Trastorno por consumo de tabaco. Resumen: Pharmacotherapy remains a relatively underused strategy for the treatment of patients with psychoactive substance-use disorders. This is partly because of a widely held view among the public and the substance-abuse treatment community that substance-use disorders are non-medical and should be treated through nonpharmacologic means. Link: ./index.php?lvl=notice_display&id=24998
in Psychiatric Clinics of North America > Año 1999- Vol. 22 No. 2 (Junio) . - pp. 401-423[artículo] Pharmacologic treatments for drug and alcohol dependence [texto impreso] / Henry R. Kranzler, Autor ; Hetal Amin, Autor ; Vania Modesto-Low, Autor . - 2020 . - pp. 401-423.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 1999- Vol. 22 No. 2 (Junio) . - pp. 401-423
Palabras clave: Alcoholismo - farmacoterapia, Antidepresivos, Trastornos relacionados con cocaína, Metadona, Narcóticos, Trastornos relacionados con opioides, Trastorno por consumo de tabaco. Resumen: Pharmacotherapy remains a relatively underused strategy for the treatment of patients with psychoactive substance-use disorders. This is partly because of a widely held view among the public and the substance-abuse treatment community that substance-use disorders are non-medical and should be treated through nonpharmacologic means. Link: ./index.php?lvl=notice_display&id=24998
Título : A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence Tipo de documento: texto impreso Autores: Raymond F. Anton, Autor ; Henry R. Kranzler, Autor ; Christopher Breder, Autor Fecha de publicación: 2023 Artículo en la página: pp. 5-12 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Antipsicóticos, Piperazinas, Quinolonas. Resumen: The purpose of this study was to compare the efficacy and safety of aripiprazole with placebo in the treatment of alcoholics. In this 12-week multicenter, double-blind study, 295 patients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition alcohol dependence were randomized to treatment with aripiprazole (initiated at 2 mg/d, titrated to a maximum dose of 30mg/d at day 28) or placebo after screening, wherein patients maintained alcohol abstinence for 3 days or more. Link: ./index.php?lvl=notice_display&id=30866
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - pp. 5-12[artículo] A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence [texto impreso] / Raymond F. Anton, Autor ; Henry R. Kranzler, Autor ; Christopher Breder, Autor . - 2023 . - pp. 5-12.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 1 (Febrero) . - pp. 5-12
Palabras clave: Alcoholismo, Antipsicóticos, Piperazinas, Quinolonas. Resumen: The purpose of this study was to compare the efficacy and safety of aripiprazole with placebo in the treatment of alcoholics. In this 12-week multicenter, double-blind study, 295 patients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition alcohol dependence were randomized to treatment with aripiprazole (initiated at 2 mg/d, titrated to a maximum dose of 30mg/d at day 28) or placebo after screening, wherein patients maintained alcohol abstinence for 3 days or more. Link: ./index.php?lvl=notice_display&id=30866
Permalink
Permalink
